Milestone Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Milestone Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 80% to $1,000,000. Profit margin reached -5968%. Total operating expenses were $62,098,000.
Profit Margin
| 2017 | 0 | -8.08M | |
|---|---|---|---|
| 2018 | 0 | -23.18M | |
| 2019 | 0 | -55.22M | |
| 2020 | 0 | -49.96M | |
| 2021 | 15M | -42.63M | -284.22% |
| 2022 | 5M | -57.13M | -1142.68% |
| 2023 | 1M | -59.68M | -5968.5% |
MIST Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 1M | 5M | 15M | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 480K | 0 | 376K | 236K | 0 | 8K |
Gross profit | 1M | 4.52M | 15M | -376K | -236K | 0 | -8K |
Operating exp. | |||||||
Research and development | 31.05M | 39.82M | 38.67M | 34.48M | 41.98M | 16.84M | 5.63M |
Selling and marketing | 15.11M | 9.09M | 7.00M | 5.93M | 8.89M | 3.92M | 1.13M |
Total operating expenses | 62.09M | 64.64M | 58.07M | 50.71M | 57.88M | 23.82M | 8.26M |
Operating income | -61.09M | -59.64M | -43.07M | -50.71M | -57.88M | -23.82M | -8.26M |
Other income (expenses), net | 1.41M | 1.25M | 220K | 726K | 2.59M | 711K | 186K |
Income before tax | -59.68M | -58.38M | -42.85M | -49.98M | -55.28M | -23.11M | -8.08M |
Income tax expense | 0 | -1.25M | -220K | -17K | -56K | 74K | 4K |
Net income | -59.68M | -57.13M | -42.63M | -49.96M | -55.22M | -23.18M | -8.08M |
Earnings per share | |||||||
Basic EPS | -1.39 | -1.35 | -1.02 | -1.7 | -3.5 | -0.98 | -0.34 |
Diluted EPS | -1.39 | -1.35 | -1.02 | -1.7 | -3.5 | -0.98 | -0.34 |
| Data source | Data source | Data source | Data source | Data source |